News & Perspective

Dec 18, 2007

Dec 18, 2007

Reports of potential H5N1 cases rise in Pakistan

(CIDRAP News) – Vigilance engendered by the possible family cluster of H5N1 avian influenza cases in Pakistan has led to many more reports of potential cases there, a World Health Organization (WHO) official said today.

Dec 14, 2007

Dec 14, 2007

Players in H5N1's debut ponder a decade's lessons

(CIDRAP News) – Dr. Keiji Fukuda still remembers the intense emotions that tumbled through his mind as he waited to board his hastily scheduled flight out of Atlanta. His destination was Asia. In Hong Kong, a newly identified avian influenza virus, recently dubbed H5N1, was making people desperately ill.

Dec 14, 2007

Pakistan suspects first human H5N1 cases

(CIDRAP News) – Reports of suspected human H5N1avian influenza cases among brothers in Pakistan are raising fresh fears in the global health community of human-to-human transmission of the virus, amid uncertainty about how a father-son pair in China contracted their H5N1 infections.

Dec 07, 2007

Dec 07, 2007

Donors pledge $406 million to fight avian flu

(CIDRAP News) – International donors at this week's New Delhi conference on avian and pandemic influenza pledged about $406 million, including $195 million from the United States, to fight H5N1 avian flu, according to news reports.

Nov 28, 2007

Nov 28, 2007

No TB found among those who flew with Atlanta patient

(CIDRAP News) – Tests have detected no tuberculosis in hundreds of people who shared airline flights with an Atlanta man who flew to Europe and back in May despite having a drug-resistant form of TB, health officials from the United States and Canada have told news services.

Nov 26, 2007

Nov 26, 2007

Virus-sharing pact eludes WHO group, but work will continue

(CIDRAP News) – A World Health Organization (WHO) group that recently met to work out an agreement to ease the global sharing of H5N1 avian influenza viruses failed to resolve the issue, but signaled that work on the issues would continue.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 14, 2007

Nov 14, 2007

Study finds greater, later role for antivirals in flu patients

(CIDRAP News) – Adults who are hospitalized with serious seasonal influenza infections are more likely to survive if they receive antiviral medications, and older patients may benefit even if treatment is delayed until more than 48 hours after their first symptoms, according to a new study by Canadian researchers.

Nov 06, 2007

Nov 06, 2007

Report says chikungunya could return in Europe next spring

(CIDRAP News) – Health experts who investigated Europe's first chikungunya outbreak involving transmission by local mosquitoes recently reported that cases could occur again next spring unless vigorous mosquito surveillance and eradication measures are used to control the disease in Italyand prevent its spread to other parts of Europe.

Nov 02, 2007

Nov 02, 2007

THE PANDEMIC VACCINE PUZZLE Part 7: Time for a vaccine 'Manhattan Project'?

Editor's note: This is the last in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»